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Abstract
The existing literature on treatment e⁄ects assumes perfect observability of the treatments
received by the population of interest. Even in cases of imperfect compliance, it is usually as-
sumed that both the assigned and administered treatment are observed (or missing completely
at random). This paper abandons such assumptions. Imperfect observability of the received
treatment can arise as a result of survey nonresponse in observational studies, or noncompliance
with randomly assigned treatments that are not directly monitored. I study the problem in the
context of observational studies. I derive sharp worst case bounds without assuming anything
about treatment selection, and I show that the bounds are a function of the available prior
information on the distribution of the missing treatments. Under the maintained assumption of
monotone treatment response, I show that no prior information on the distribution of missing
treatments is necessary to get sharp informative bounds. I apply the methodologies recently
proposed by Imbens and Manski (2004) and Chernozhukov, Hong, and Tamer (2004) to derive
two types of con￿dence intervals for the partially identi￿ed parameters. The results are illus-
trated with an empirical analysis of drug use and employment using data from the National
Longitudinal Survey of Youth.
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Part of the existing literature on programme evaluation has examined what can be inferred about
a treatment e⁄ect of interest when the observability of some of the relevant variables is imperfect,
and when noncompliance to assigned treatments prevents identi￿cation in randomized experiments.
Little (1992), Robins, Rotnizky, and Zhao (1994), and Wang, Wang, Zhao, and Ou (1997) formulate
sets of assumptions strong enough to achieve point identi￿cation for the case of missing covariate
data. Imbens and Pizer (1999) show that in randomized experiments with complete random as-
signment of treatment, the assumption of covariate data missing at random can be tested. They
develop models that allow to achieve point identi￿cation, are consistent with the restrictions im-
plied by the complete random assignment of treatment, and are as close to the assumption of data
missing at random as possible. Horowitz and Manski (2000) study the problem of missing outcome
and covariate data in randomized experiments. They derive sharp bounds on the distribution of
outcomes conditional on covariates without invoking untestable assumptions on the missing data
mechanism. Angrist, Imbens, and Rubin (1996) address the problem of imperfect compliance in
classical randomized experiments; they pose a set of assumptions under which it is possible to
identify the treatment e⁄ect within the subpopulation of persons who comply with the assigned
treatment. Robins (1989) and Balke and Pearl (1994), (1995) and (1997) study similar identi￿-
cation problems under weaker assumptions; in particular Balke and Pearl (1997) make use of the
statistical independence between the response functions and the assigned treatments to propose
alternative, assumption-free sharp bounds for assessing the average e⁄ect of treatment over the
population as a whole. A di⁄erent problem is addressed by Hotz, Mullin, and Sanders (1997), who
study what can be learned about treatment e⁄ects when one uses a contaminated instrumental
variable, i.e. when a mean-independence assumption holds in a population of interest, but the
observed population is a mixture of the population of interest and one in which the assumption
doesn￿ t hold.
A common feature in this literature is the assumption of perfect observability of the received
treatment (both in randomized experiments and observational studies), or ignorability of the data
with missing treatments. This assumption is often at odds with the empirical evidence. Survey
nonresponse can a⁄ect the observability of a variable whose e⁄ect is under study, and often it is not
plausible to assume that the decision to respond to a speci￿c question in a survey is random. For
example, researchers face relatively high nonresponse rates when studying the e⁄ect of ￿problem
drinking￿or drug abuse on labor market outcomes (see for example Mullahy and Sindelar (1995),
Kaestner (1991), (1994) and (1998), and Kaestner and Grossman (1995)); at the same time, it
doesn￿ t seem plausible to assume that the fraction of drug abusers or alcoholics is identical for
respondents and nonrespondents (see for example Pepper (2001)). Another example comes from
1Robins (1997), who describes a nonrandomized experiment in which observation of a treatment
group and a control group of women who had a breast cancer is used to infer the e⁄ect of radiation
therapy on the development of a second cancer. While the outcome is observable for all subjects,
the treatment (as well as some of the covariates) is missing for some of the subjects. Robins suggests
assumptions on the missing data processes that imply point identi￿cation.
In practice, in applied work it is often assumed that the data are missing completely at random,
and complete case (CC) analysis is conducted (see Little and Rubin (1987), Chapter 3, for a
critical presentation of CC analysis). In this paper I examine the missing treatments problem from
a ￿conservative￿perspective, in the sense that I ￿rst determine the inferences that can be drawn in
the absence of assumptions about the missing data mechanism and then illustrate the identifying
power of widely credible assumptions posed on the distribution of the missing treatments and on
the treatment selection rule.
In the setting considered here there are three problems preventing point identi￿cation of treat-
ment e⁄ects: the usual latent outcome problem, the impossibility of identifying the distribution
of received treatments, and the impossibility of matching the unobserved received treatments with
the observed outcomes. I will propose a method to jointly address these problems. As will appear
from the analysis of the following sections, signi￿cant progress can be made when the researcher
has some prior information on the distribution of the missing treatments.
The paper is organized as follows: Section 2 introduces the relevant notation and the questions
of interest. Section 3 introduces the empirical illustration, which focuses on the e⁄ect of drug
abuse during work hours on unemployment, and shows that the assumption of ignorability of the
observations with missing treatment data can be rejected for this problem. Section 4 derives worst
case bounds on the treatment e⁄ects of interest. I show that in observational studies, when nothing
is assumed about the distribution of the missing treatments, no information can be extracted from
the observations for which the received treatment is unknown, and the additional degree of under-
identi￿cation is proportional to the fraction of missing data. However, if some prior knowledge
of the marginal distribution of the unobservable received treatments is available, some progress
can be made. In Section 5 I show that under the maintained assumption of monotone treatment
response (Manski (1997)), such prior knowledge is not necessary to extract information from the
observations for which the received treatment is unknown. The bounds derived in this paper are
sharp, in the sense that they exhaust all information available from the data and the maintained
assumptions. In Sections 3-5, to keep the focus on identi￿cation, I treat identi￿ed quantities as
known. Section 6 addresses statistical considerations by deriving two types of con￿dence intervals:
a type that asymptotically covers the identi￿cation regions with a prespeci￿ed probability, following
the approach of Chernozhukov, Hong, and Tamer (2004), and a type that asymptotically covers
the true parameter of interest (rather than its identi￿cation region) with at least a prespeci￿ed
2probability, following the approach of Imbens and Manski (2004). Section 7 presents the results of
the empirical illustration. Section 8 concludes.
2 Setup of the Problem
Using standard notation (e.g., Neyman (1923)), let each member j of a population of interest J be
characterized by some covariates xj 2 X, be exposed to a set of mutually exclusive and exhaustive
treatments T, and have a speci￿c response function yj (￿) : T ! Y mapping treatments t 2 T into
outcomes yj (t) 2 Y . If zj 2 T is the treatment that individual j actually receives, then yj ￿ yj (zj)
is the realized outcome, while yj (t) is a latent outcome for t 6= zj. Denote by dj a binary variable
which takes value 1 if the treatment received by individual j is observed, 0 otherwise, and assume
that the population is a measure space (J;￿;P), with a probability measure P. In the analysis
developed in this paper I assume perfect observability of realized outcomes as well as covariates; I
also assume that all variables are correctly measured. Such assumptions are maintained in order to
focus attention on the problem of missing treatments; Horowitz and Manski￿ s (1995, 1998 and 2000)
results can be easily incorporated in the analysis in case of missing or contaminated outcome data,
or missing covariate data. Molinari￿ s (2005) results can be applied in the presence of classi￿cation
error in the outcome data, the covariate data, or the treatment data.
The researcher learns the distribution P [y;x;d] of realized outcomes, covariates, and observ-
ability of realized treatments, and the distribution P [zjx;y;d = 1] of realized treatments given
covariates, realized outcome and observability of the realized treatment. The researcher￿ s prob-
lem is to learn the distribution P [y (￿)jx] of response functions, in order to infer the e⁄ect of a
treatment.
I study the problem of missing treatments in the context of observational studies; however this
problem can appear as well in randomized experiments, either because the assigned treatments
are partially unobservable, or because there is uncertainty about the degree of compliance of the
individuals with the treatments. If there is full compliance and partial unobservability of the
assigned treatment, it is easy to show that the problem can be expressed as a case of missing
covariates identical to the one studied by Horowitz and Manski (1998), so their results apply.1 If
there is perfect observability of the assigned treatment but uncertainty on the degree of compliance,
the problem can be approached adapting the method of Balke and Pearl (1994)-(1997). They
consider the problem of an experimental study where random assignment has taken place, but
compliance is not perfect (i.e. the treatment received di⁄ers from that assigned). In case of
observability of the received treatments, Balke and Pearl (1994)-(1997) derive sharp bounds on the
1If the treatments are randomly assigned, the treatment e⁄ect of interest can be evaluated by means of a regression
of realized outcomes on treatments.
3average treatment e⁄ect by solving a complex linear programming problem. The same method can
be used in case of unobservability of the received treatment or uncertainty about the degree of
compliance, as long as we can perfectly observe d (if it is only known that a fraction of the agents
doesn￿ t comply with the assigned treatments, but it is not known who does not comply, the method
below does not apply, as we are facing a contamination problem).
To simplify notation I omit the covariates in all that follows. I assume that the outcome variable
y takes values in a bounded set Y; where K0 ￿ inf Y and K1 ￿ supY are known ￿nite numbers.
For ease of exposition I assume that T = f0;1g; in case of multiple treatments, all of the results in
Sections 4 and part of the results in Section 5 (to be speci￿ed below) still hold. Since the focus of
this paper is on the missing treatments problem, I assume 0 < Pr(d = 0) < 1. The questions to be
addressed are:2
￿ what can be learned about E [y (t)]; t 2 T, the average outcome under a mandatory policy;
￿ what can be learned about E [y (1)] ￿ E [y (0)], the average treatment e⁄ect (ATE).
3 Empirical Application
3.1 The E⁄ect on Unemployment of Drug Use During Work Hours
Illicit drug and alcohol abuse have generally been associated with huge economic costs, and such
association has been a motivation for drug-related and alcohol-related public policies in the US
and worldwide. A large share of these costs is related to reduced labor productivity. Harwood,
Fountain, and Livermore (1998) report that in 1992 alcohol and drug abuse cost society an esti-
mated $176.4 billion as a result of (i) lost productivity, due to premature death and illness among
abusers, (ii) crime-related costs of abusers, (iii) time abusers spent in residential treatment, and
(iv) developmental disabilities among fetal alcohol syndrome survivors. Shortfalls in productivity
and employment among individuals with alcohol or drug abuse disorders accounted for estimated
losses of $80.9 billion in lost productivity ($66.7 billion resulting from alcohol problems and $14.2
billion from drug problems).3 Harwood, Fountain, and Livermore (1998) report as well that in
the subpopulation of enrollees in publicly funded treatment providers, chronic and severe alcohol
and drug abusers appear often to have great di¢ culties obtaining and keeping stable employment.
Those who do have a job may often be intoxicated or high and unable to work, and commonly
move from one part-time job to another.
2Formal results on what can be learned about E [y (t)] ￿ E [y (z)], i.e. the status quo treatment e⁄ect (STE), are
available from the author upon request.
3These estimates were constructed using the data from the National Longitudinal Alcohol Epidemiologic Survey,
and the microsimulation techniques used in studies of the RAND Health Insurance Experiment.
4It may seem logical to expect a negative relationship between the presence and severity of an
alcohol and/or drug abuse problem and the employment status, labor supply, and wage rate of
individuals. However, while there is evidence that ￿problem drinking￿is associated with lower em-
ployment rates and greater unemployment,4 the ￿ndings on the e⁄ects of drug use on labor market
outcomes are still controversial. For example Kandel and Davies (1990), Kaestner (1991), Register
and Williams (1992), and Gill and Michaels (1992) ￿nd that drug use is positively correlated with
wages, even when one accounts for individual characteristics and endogeneity. At the same time,
Kaestner (1994) and Buchmueller and Zuvekas (1998) ￿nd signi￿cant negative e⁄ect of drug use
on employment or labor supply for males, but insigni￿cant or positive e⁄ect for females (Kaestner
(1994)). Kandel and Yamaguchi (1987) study the e⁄ect of drug use on job mobility, and show that
drug use predicts job turnover and decreased tenure on the job; however their results suggest that
these e⁄ects probably re￿ ect the in￿ uence of preexisting di⁄erences among individuals who start
using drugs instead of the e⁄ects of drugs themselves.
One of the problems which a⁄ect the empirical work in this area is the relatively high fraction
of missing data (see for example Pepper (2001)); people are reluctant to answer questions relative
to illicit activities or stigmatized activities, like drug abuse or ￿problem drinking￿ . In practice,
researchers often assume that the data are missing completely at random (MCAR), and conduct
their analysis only on the subpopulation of respondents. I adopt a more conservative approach and
study the e⁄ect for the population as a whole of drug use during work hours on the probability of
being ￿red, discharged or laid o⁄.
3.2 Data
I use data from the National Longitudinal Survey of Youth (NLSY). In its base year of 1979 the
NLSY interviewed 12;686 persons who were between the age of 14 to 22 at that time. The survey
has been updated each year since 1979 (and every two years since the early 1990￿ s). The data
contain detailed information on a respondent￿ s labor market experience, and family and personal
background. Approximately half of the total NLSY respondents were randomly sampled, the
remaining being selected to overrepresent certain demographic groups (see BLS (1999)). In all that
follows I restrict attention to the randomly sampled subpopulation; hence, problems connected
with sampling design can be ignored. In 1984 and 1988 the respondents were asked questions
about their lifetime and current use of several illicit drugs. In 1984, a (randomly sampled) group
of 1;441 respondents who had been employed either in that year or in the past were asked whether
(on their most recent job since the 1983 interview) they had been under the e⁄ect of illicit drugs
during work hours.
4See for example Mullahy and Sindelar (1995).
5While self reports may provide a great deal of information about an individual￿ s behavior, the
validity of such reports is sometimes questioned. Mensch and Kandel (1998) compare the declared
illicit drugs use in the 1984 youth survey with the reports of other national surveys of drug use,
and ￿nd underreporting of drug abuse (other than marijuana). But they as well suggest that such
underreporting seems to be more common among light drug users than heavy users, and more
common among blacks and Hispanics than among whites. As Gleason, Veum, and Pergamit (1991)
argue, it may be that individuals who use drugs at work are more frequent users, and as Mensch
and Kandel (1998) document less likely to underreport their drug use. Embracing this argument, in
the analysis which follows I will assume that whenever an individual chooses to answer the question
on drug use during work hours, she/he answers the truth.5 However, as drug use at work may be
a highly socially unacceptable activity, I will allow for the decision to not respond to the questions
to be motivated by respondents￿reluctance to report that they did engage in such activity.
I will focus attention on the 1345 (randomly sampled) respondents who were employed in 1983.
Thus my empirical analysis concerns the subpopulation of persons who, in the notation introduced
in Section 2 (and which will be left implicit in Sections 4-7), have the shared observable covariate
x = femployed in 1983g: Additional covariates will be brie￿ y considered in the next subsection.
Out of this group, 236 persons answered that they did use drugs during work hours, 994 answered
that they did not, and 115 refused to answer the question (8:55%). I take the outcome of interest
to be the number of weeks an individual was unemployed during the calendar year 1983-84. If
the respondent answered the question on drug abuse (dj = 1), we observe whether she has been
under the e⁄ect of drugs during work hours (zj = 1jdj = 1) or not (zj = 0jdj = 1); if the
respondent skipped the question, we register the missing data (dj = 0). In the subpopulation of
respondents, the average number of weeks of unemployment is relatively low regardless of drug
use. Abstracting from sample variability, E [yjz = 1;d = 1] = 3:267, and E [yjz = 0;d = 1] =
2:703, while Pr[z = 1jd = 1] = 0:192. If one were to assume random treatment selection (i.e.
z ? fy (0);y (1)g) and ignorability of the observations with missing treatment data (i.e. d ?
fy (0);y (1);zg), he would conclude that the average treatment e⁄ect is equal to 0:564 weeks. This
would imply that drug use increases the average number of weeks of unemployment in a calendar
year by little over half a week. Table 1 summarizes these descriptive statistics, along with their
95% con￿dence intervals.
3.3 Testing for MCAR and for Validity of the Complete Case Analysis
When facing missing data problems as the one described above, researchers often conduct ￿complete
case￿analyses, in which observations with any missing values are simply discarded (Little (1992)).
5This assumption can be relaxed, allowing for misreporting of drug use during work hours, using the direct
misclassi￿cation approach of Molinari (2005).
6Table 1: NLSY Descriptive Statistics, N=1345
Point Est. 95% CI
Probability of missing treatments: Pr[d = 0] 0:086 [0:071 ; 0:100]
Probability of drug use given observable treatments: Pr[z = 1jd = 1] 0:192 [0:170 ; 0:214]
Average number of weeks of unemployment in subpopulation for whom
treatments are observed and drugs are used: E[yjz = 1;d = 1] 3:267 [2:322 ; 4:212]
Average number of weeks of unemployment in subpopulation for whom
treatments are observed and drugs are not used: E[yjz = 0;d = 1] 2:703 [2:303 ; 3:103]
Average number of weeks of unemployment in subpopulation for whom
treatments are observed: E[yjd = 1] 2:811 [2:441 ; 3:182]
Average number of weeks of unemployment in subpopulation for whom
treatments are not observed: E[yjd = 0] 1:930 [1:502 ; 2:359]
Di⁄erence in the average number of weeks of unemployment between
subpopulation for whom treatments are observed and for whom
treatments are unobserved: E[yjd = 1]￿E[yjd = 0] 0:881 [0:314 ; 1:448]
ATE assuming exogenous treatment selection and treatments missing
completely at random: E[yjz = 1;d = 1]￿E[yjz = 0;d = 1] 0:564 [￿0:462 ; 1:590]
In the context of treatment e⁄ects, when the treatment data are partially unobservable, this can
lead to valid inference if: (i) the treatment data are MCAR, (ii) d ? f(y (0);y (1))jxg, (iii) d ?
f(y (0);y (1);z)jxg. Note that assuming P [y (t)jz;d;x] = P [y (t)jz;x] alone does not imply
validity of the CC analysis. Validity would be assured if one assumed also that Pr(z = tjd;x) =
Pr(z = tjx). The assumption d ? f(y (0);y (1))jxg, is not testable, and in general it does not
seem appealing. For example, if Pr(z = tjd;x) 6= Pr(z = tjx) and P [y (t)jz;d;x] = P [y (t)jz;x],
it follows that P [y (t)jx;d = 1] 6= P [y (t)jx;d = 0]. Similarly, if Pr(z = tjd;x) = Pr(z = tjx) and
P [y (t)jz;d;x] 6= P [y (t)jz;x], it follows again that P [y (t)jx;d = 1] 6= P [y (t)jx;d = 0].
On the other hand, a necessary condition for the assumption d ? f(y (0);y (1);z)jxg; as well
as for the assumption MCAR, to hold can be tested. In particular, the following result is easy to
verify:
Lemma 1 Suppose that d ? f(y (0);y (1);z)jxg. Then
P [yjd = 1;x] = P [yjd = 0;x] (1)
Clearly, if the observability of the treatments is independent from the response functions and
from the received treatments conditional on the observed covariates, the distribution of realized
7outcomes, conditional on the observed covariates, for the subpopulation for whom the received
treatments are observable should be the same as that for the subpopulation with missing treatment
data. In practice, before conducting CC analyses, one can test whether the equality in (1) holds.
Note that if the assumptions P [y (t)jz;d;x] = P [y (t)jz;x] and P (zjd;x) = P (zjx) are jointly
maintained, condition (1) should again hold, and therefore the same test as described in Lemma 1
can be performed. However in both cases, condition (1) is only necessary but not su¢ cient for the
CC analysis to be valid, or for the MCAR assumption to hold.
Given the NLSY sample, for x = femployed in 1983g a Wilkoxon rank-sum test rejects the
equality in (1) at the 5% signi￿cance level. Conditioning on additional covariates, the equality in
(1) can again be rejected. For example, if we look at the group of respondents employed in 1983,
younger than 24, with at least a high school degree, we can again reject the null at 5% signi￿cance
level.
4 Worst Case Bounds
The following Subsections 4.1-4.2 analyze what can be learned about the treatment e⁄ects of
interest when nothing is assumed about the distribution of the missing treatments. The availability
of prior information on this distribution will turn out to be crucial: if nothing is known about
Pr[z = 1jd = 0], no information can be extracted from the observations for which the treatments
are missing. However, if a bound (or point identi￿cation) on Pr[z = 1jd = 0] is available, it is
possible to extract information from the observations with missing treatment data; Subsection 4.3
discusses how.
4.1 Worst Case Bounds on a Mandatory Policy
Suppose that we are interested in E [y (1)]; by the Law of Iterated Expectations
E [y (1)] = E [y (1)jd = 1]Pr(d = 1) + E [y (1)jd = 0]Pr(d = 0) (2)
From the data we can learn Pr(d = 1) and Pr(d = 0); regarding the other two terms on the
right hand side of (2), let us ￿rst focus our attention on E [y (1)jd = 1]:
E [y (1)jd = 1] = E [yjd = 1;z = 1]Pr[z = 1jd = 1] + E [y (1)jd = 1;z = 0]Pr[z = 0jd = 1] (3)
The equality in (3) expresses the usual problem of learning the distribution of outcomes under
a mandatory policy (in this case assigning treatment 1): the only unobserved quantity is the
counterfactual probability of success under the treatment for people who actually did not receive
it: E [y (1)jd = 1;z = 0].
8Let us now consider E [y (1)jd = 0]:
E [y (1)jd = 0] = E [yjd = 0;z = 1]Pr[z = 1jd = 0] + E [y (1)jd = 0;z = 0]Pr[z = 0jd = 0] (4)
The problem arising in the case of missing treatments is that all quantities in (4) are unknown:
not only do we have the usual problem of latent outcomes, but we also do not know the distribution
of treatments when they are unobservable; moreover the data do not reveal how to match the
realized outcome with the received but unobservable treatment. The only thing we can learn from
the data is the distribution of realized outcomes under unobserved treatments, i.e. we can learn
Q(t) ￿ Pr[y ￿ tjd = 0] = Pr[y ￿ tjd = 0;z = 1]p + Pr[y ￿ tjd = 0;z = 0](1 ￿ p)
where p ￿ Pr[z = 1jd = 0]. If p is known, it is possible to use the result of Corollary 4.1 in Horowitz
and Manski (1995) to ￿nd a sharp bound on E [y (1)jd = 0] using the information provided by Q
(similarly for E [y (0)jd = 0]). However, if we do not know anything about p, knowledge of Q does
not help to bound the outcome distribution under received treatment unobservability. Indeed, it
may be that all treatments we do not observe are of type 0, in which case knowledge of Q does not
provide any information about E [y (1)].
Proposition 1 states what can be learned about a mandatory policy, both when p is known and
when p is unknown. Before stating the result, I need to introduce some additional notation: for
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9In absence of knowledge of p, the sharp bounds on E [y (1)jd = 0] and on E [y (1)] are given by:
K0 ￿ E [y (1)jd = 0] ￿ K1 (7)
E [yjd = 1;z = 1]Pr[z = 1;d = 1] + (P [z = 0;d = 1] + Pr(d = 0))K0 ￿
E [y (1)] ￿ E [yjd = 1;z = 1]Pr[z = 1;d = 1] + (P [z = 0;d = 1] + Pr(d = 0))K1
Proof. See Appendix.
While the width of the bound on E [y (1)] with no missing data is equal to Pr[z = 0](K1 ￿ K0) =
Pr[z = 0jd = 1](K1 ￿ K0), with missing treatments it increases to (Pr[z = 0jd = 1]Pr(d = 1)+
Pr(d = 0))(K1 ￿ K0). This expression can be rewritten as
(Pr[z = 0jd = 1] + Pr[z = 1jd = 1]Pr(d = 0))(K1 ￿ K0):
It is then easy to see that the increase in the width is proportional to Pr[z = 1jd = 1]Pr(d = 0),
and hence, for given fraction of individuals observed to receive treatment 1, proportional to the
fraction of missing data.
4.2 Worst Case Bounds on the Average Treatment E⁄ect
Consider now the case in which the researcher is interested in learning about the average treatment
e⁄ect (ATE)
E [y (1)] ￿ E [y (0)] (8)
As we did for E [y (1)], we can decompose the quantity in (8) using the Law of Iterated Expectations:
E [y (1)] ￿ E [y (0)] = fE [y (1)jd = 1] ￿ E [y (0)jd = 1]gPr(d = 1)
+fE [y (1)jd = 0] ￿ E [y (0)jd = 0]gPr(d = 0)
Let us ￿rst consider the ATE under observability of the received treatment. A sharp bound on
this quantity can be found using results well known in the literature (e.g., Manski (1995)):
LBd=1




ATE = E [yjd = 1;z = 1]Pr[z = 1jd = 1] + K0 Pr[z = 0jd = 1]
￿E [yjd = 1;z = 0]Pr[z = 0jd = 1] ￿ K1 Pr[z = 1jd = 1]
(10)
UBd=1
ATE = E [yjd = 1;z = 1]Pr[z = 1jd = 1] + K1 Pr[z = 0jd = 1]
￿E [yjd = 1;z = 0]Pr[z = 0jd = 1] ￿ K0 Pr[z = 1jd = 1]
(11)
10Note that the width of this bound is exactly (K1 ￿ K0), as for the usual ATE.
Consider now the ATE under unobservability of the received treatment. In what follows let
Pr[z = 1jd = 0] ￿ p P [yjd = 0] ￿ Q
E [yjd = 0;z = 1] ￿ E11 E [y (1)jd = 0;z = 0] ￿ E10
E [yjd = 0;z = 0] ￿ E00 E [y (0)jd = 0;z = 1] ￿ E01
Then we can restate the problem as to ￿nd a bound on
E [y (1)jd = 0] ￿ E [y (0)jd = 0] = E11p + E10 (1 ￿ p) ￿ E00 (1 ￿ p) ￿ E01p (12)
Note that all quantities on the right hand side of (12) are unknown; however, for a given value
of p we can extract information from the knowledge of Q. As p ranges from 0 to 1 we move from
knowing exactly the value of E11, to having decreasing information on it and increasing information
on E00, to knowing exactly the value of E00. Even if E01 and E10 are unknown, using this fact we can
￿nd a sharp p-dependent bound on the average treatment e⁄ect under treatment unobservability.
Proposition 2 Given the value of p 2 [0;1] and no other information, the sharp bound on














For any value of p this bound is informative. The sharp bound on E [y (1)] ￿ E [y (0)] is given by:
LBd=1
ATE ￿ Pr(d = 1) + LBd=0
ATE ￿ Pr(d = 0) ￿ E [y (1)] ￿ E [y (0)] (14)
￿ UBd=1
ATE ￿ Pr(d = 1) + UBd=0
ATE ￿ Pr(d = 0)
where LBd=1
ATE and UBd=1
ATE were de￿ned in (10)-(11).
In absence of knowledge of p, the sharp bounds on E [y (1)jd = 0]￿E [y (0)jd = 0] and on E [y (1)]￿
E [y (0)] are given by:
￿(K1 ￿ K0) ￿ E [y (1)jd = 0] ￿ E [y (0)jd = 0] ￿ (K1 ￿ K0) (15)
LBd=1
ATE ￿ Pr(d = 1) ￿ (K1 ￿ K0)Pr(d = 0) ￿ E [y (1)] ￿ E [y (0)] (16)
￿ UBd=1
ATE ￿ Pr(d = 1) + (K1 ￿ K0)Pr(d = 0):
The width of the band in (16) is equal to (K1 ￿ K0)(1 + Pr(d = 0)).
Proof. See Appendix.
114.3 Identifying Power of Assumptions on Pr[z = 1jd = 0]
The bounds derived in Propositions 1 and 2 are functions of p ￿ Pr[z = 1jd = 0]. We showed
that as long as p is unknown no information can be extracted from the observations with missing
treatment data. However, if some prior information on the distribution of the missing treatments
is available, some progress can be made.6
Suppose for example that p is identi￿ed, either because the results of a validation study are
available, or because one is willing to assume that the treatments are missing at random,7 i.e.
d ? z, which implies p = Pr[z = 1jd = 1]. Then the bounds reported in Propositions 1 and 2 can
be evaluated at this value of p.
Alternatively, one may learn that p 2 [p1;p2]. For example, if the survey from which the data are
drawn concerns activities to which a stigma is associated (e.g.: illicit drug use), the decision not to
respond to the questions can be motivated by respondents￿reluctance to report that they engaged
in such activities. In this case, it may be credible to assume that the probability of having engaged
in such activities for people who didn￿ t answer the survey is not smaller than for people who did
answer the question. Pepper (2001) introduces an assumption of this type. Then the bound on the
ATE can be calculated by taking (respectively) the in￿mum value and the supremum value that
the lower bound and the upper bound reported in Proposition 2 achieve for p ranging in [p1;p2].
Regarding the mandatory policy, the bound on E [y (1)] can be calculated by evaluating the bound
in Proposition 1 at p = p1 (while the information provided by p2 can be used to bound more tightly
E [y (0)]).8
5 Missing Treatments with Monotonicity Assumptions
Manski (1997) investigates what may be learned about treatment response when it is assumed that
response functions are monotone, semi-monotone, or concave monotone, and no assumptions are im-
posed on the treatment selection process. He shows that assuming monotone or concave monotone
response qualitatively improves the identi￿cation problem relative to the worst case situation in
which no prior information is available. Manski and Pepper (2000) study the identifying power
of monotone instrumental variable assumptions, and in particular the special case of monotone
treatment selection (MTS). They show that the joint assumption of monotone treatment selection
6A more detailed derivation of the identifying power of assumptions on P [z = 1jd = 0] is available from the author
upon request.
7Note that in this case we are not assuming d ? (y (0);y (1);z).
8Another example along these lines is given by recent work of Kreider and Hill (2005), who apply some of the
results in this paper to study the problem of learning utilization rates of health services under a hypothetical policy
of universal health insurance, when insurance status is subject to classi￿cation error and is unveri￿ed for some
respondents (the respondents with missing treatments).
12and response can be tested, and that if such joint assumption is maintained, informative bounds
are obtainable even if Y is unbounded.
In this section I study the identifying power of assuming monotone treatment response (MTR),
and of jointly assuming monotone treatment response and selection (MTR￿MTS), when some of
the treatments are missing. I show that under the maintained assumption of monotone treatment
response (alone or jointly with MTS), one can extract information from the observations for which
the treatment data are missing even without any prior knowledge of p ￿ P [z = 1jd = 0]. Clearly,
prior information on p will further shrink the bounds.
Let us assume that the response function is weakly increasing; in the case studied here, since
T = f0;1g, this implies that for each j 2 J:
yj (0) ￿ yj (1) (17)
To interpret this assumption, consider the example of the e⁄ect of drug abuse during work hours
on the number of weeks an individual is unemployed in a calendar year. The monotone treatment
response assumption implies that each person￿ s unemployment outcome is weakly increasing in
conjectured use of drugs during work hours.
If (17) holds, we can use the results of Manski (1997) to tighten the bounds on the quantities
of interest given observability of the received treatment; in particular we get the following sharp
bounds:
K0 Pr[z = 1jd = 1] + E [yjz = 0;d = 1]Pr[z = 0jd = 1] ￿ E [y (0)jd = 1] ￿ E [yjd = 1] (18)
E [yjd = 1] ￿ E [y (1)jd = 1] ￿ E [yjz = 1;d = 1]Pr[z = 1jd = 1] + K1 Pr[z = 0jd = 1] (19)
Under the MTR assumption we can as well extract information from knowledge of the dis-
tribution of realized outcomes given unobservability of the treatment, and get tighter bounds on
E [y (0)jd = 0] and E [y (1)jd = 0]. Then, through the Law of Iterated Expectations and given
(18)-(19), we get narrower bounds on E [y (0)] and E [y (1)].
Proposition 3 Suppose that the treatment response function is weakly increasing. Then:
K0 ￿ E [y (0)jd = 0] ￿ E [yjd = 0]
E [yjd = 0] ￿ E [y (1)jd = 0] ￿ K1
(20)
and
K0 Pr[z = 1;d = 1] + E [yjz = 0;d = 1]Pr[z = 0;d = 1] + K0 Pr(d = 0) ￿ (21)
E [y (0)] ￿ E (y)
13E (y) ￿ E [y (1)] (22)
￿ E [yjz = 1;d = 1]Pr[z = 1;d = 1] + K1 Pr[z = 0;d = 1] + K1 Pr(d = 0)
0 ￿ E [y (1)] ￿ E [y (0)] ￿ (
(E [yjz = 1;d = 1] ￿ K0)Pr[z = 1;d = 1]
+(K1 ￿ K0)Pr(d = 0) + (K1 ￿ E [yjz = 0;d = 1])Pr[z = 0;d = 1]
)
(23)
In absence of additional information, these bounds are sharp.
Proof. See Appendix.
The result in (20) is quite intuitive: if we assume yj (0) ￿ yj (1), it follows that assigning
treatment 0 as a mandatory policy can￿ t imply a larger outcome than the realized one, while
assigning treatment 1 as a mandatory policy can￿ t imply a smaller outcome than the realized one.
In case of multiple treatments, i.e. T = ft1;t2;:::;tNg and t1 ￿ t2 ￿ ::: ￿ tN, one can use
the results in (20) to get tighter bounds on E [y (t1)jd = 0] and on E [y (tN)jd = 0]. However
no information can be extracted from the observations with incomplete data in order to tighten
the bounds on E [y (t)jd = 0] for 8 t 2 T;t 6= t1;tN, unless prior information is available on
Pr[z = 1jd = 0]: Regarding E [y (t)jd = 0] ￿ E [y (s)jd = 0], under the MTR Assumption this
quantity ranges in [0;K1] for 8 t;s 2 T, t > s.
Let us now assume that E [y (t)jz = u] is weakly increasing in u; let￿ s assume further that
this restriction holds for the subpopulation with complete data. In the case studied here, since
T = f0;1g, this implies that for each t 2 T:
E [y (t)jz = 1;d = 1] ￿ E [y (t)jz = 0;d = 1] (24)
To interpret this assumption, consider the example of the e⁄ect of drug abuse during work hours
on the average number of weeks of unemployment. The monotone treatment selection assumption
implies that, for each t 2 T, persons who do not select into using drugs during work hours experience
a weakly lower average number of weeks of unemployment than do people who do select into using
drugs during work hours. Note that I require such assumption to hold for the subpopulation for
which treatments are observable since to make use of it one needs to observe the received treatments.
This implies that the MTS Assumption does not have identifying power on E [y (t)jd = 0], unless
prior information is available on Pr[z = 1jd = 0]:
Given (24), we can use the results of Manski and Pepper (2000) to tighten the bounds on the
quantities of interest given observability of the received treatment; in particular we get the following
sharp bounds:
E [yjz = 0;d = 1] ￿ E [y (0)jd = 1] ￿ E [yjz = 0;d = 1]Pr[z = 0jd = 1] + K1 Pr[z = 1jd = 1]
14K0 Pr[z = 0jd = 1] + E [yjz = 1;d = 1]Pr[z = 1jd = 1] ￿ E [y (1)jd = 1]
￿ E [yjz = 1;d = 1]
If one is willing to impose jointly the MTR and MTS assumptions, the width of the bounds
shrinks signi￿cantly. In particular, for the subpopulation with no missing data, under the joint
MTR ￿ MTS Assumption
E [yjz = 0;d = 1] ￿ E [y (0)jd = 1] ￿ E [yjd = 1] (25)
E [yjd = 1] ￿ E [y (1)jd = 1] ￿ E [yjz = 1;d = 1] (26)
0 ￿ E [y (1)jd = 1] ￿ E [y (0)jd = 1] ￿ E [yjz = 1;d = 1] ￿ E [yjz = 0;d = 1] (27)
The following Proposition, which can be easily veri￿ed given the results in (20), the results
in (25)-(27), and the Law of Iterated Expectations, shows what are the bounds on the treatment
e⁄ects of interest under the joint MTR ￿ MTS Assumption.
Proposition 4 Suppose that (17) and (24) jointly hold. Then:
E [yjz = 0;d = 1]Pr(d = 1) + K0 Pr(d = 0) ￿ E [y (0)] ￿ E (y)
E (y) ￿ E [y (1)] ￿ E [yjz = 1;d = 1]Pr(d = 1) + K1 Pr(d = 0)
0 ￿ E [y (1)] ￿ E [y (0)]
￿ fE [yjz = 1;d = 1] ￿ E [yjz = 0;d = 1]gPr(d = 1) + (K1 ￿ K0)Pr(d = 0)
In absence of additional information, these bounds are sharp.
The joint MTR ￿ MTS Assumption is a testable hypothesis, which should be rejected if
E [yjz = u] is not weakly increasing in u. When some of the treatments are missing, it is straight-
forward to show that such assumption can still be tested on the subpopulation for which the
treatments are observable. However the hypothesis cannot be tested on the subpopulation with
missing data, and hence on the population as a whole.
6 Con￿dence Sets for the Parameters of Interest and for the Iden-
ti￿cation Regions
Con￿dence intervals which asymptotically cover the identi￿cation regions derived in Sections 4-5
with a prespeci￿ed probability (1 ￿ ￿) can be obtained by using the results of Chernozhukov, Hong,
15and Tamer (2004). A conceptually di⁄erent type of con￿dence regions that asymptotically cover the
true parameter of interest (rather than its identi￿cation region) with probability at least (1 ￿ ￿) can
be obtained by using the results of Imbens and Manski (2004). In both cases, denoting by ^ #L and
^ #U the estimated lower and upper bound for a certain parameter of interest, the con￿dence interval
is of the form
h
^ #L ￿ cL￿; ^ #U + cU￿
i
; where cL￿ and cU￿ depend on the critical value of a certain
distribution, which di⁄ers in the two approaches, and on the sample size. In this paper I utilize
both methodologies, and compare the con￿dence intervals obtained for the empirical application in
Section 7.
Chernozhukov, Hong and Tamer (2004) discuss how to construct con￿dence sets for identi￿-
cation regions of parameters obtained as the solution of the minimization of a criterion function.
They also discuss how to construct con￿dence regions when the object of interest is a parameter
of the form E [y (1)] or E [y (1) ￿ y (0)]; the identi￿cation region for such parameter is the entire
interval between two functionals of the distribution of the observed data (^ #L and ^ #U), and the
estimates of the lower and upper bounds converge at the parametric rate. In order to be able to
use their result, I need to derive the joint asymptotic distribution of the sample analogs of each of
the lower and upper bounds obtained in Sections 4-5. Using standard arguments on the asymptotic
properties of sample means and L-statistics (Shorack and Wellner (1986), Chapter 19), I provide
these results in Appendix B.
The con￿dence intervals proposed by Imbens and Manski (2004) asymptotically cover the true
parameter of interest with at least a prespeci￿ed probability. They are designed for intervally
identi￿ed parameters, and require the derivation of the joint asymptotic distribution of the sample
analogs of the lower and upper bounds of the parameter of interest. However, in order to ensure
uniformity in the coverage properties of their con￿dence intervals (and to avoid anomalies in the
width of the con￿dence intervals that arise as one approaches point identi￿cation), Imbens and
Manski (2004) require that a uniform central limit theorem hold for the joint asymptotic distribution
of the sample analogs of each of the lower and upper bounds of interest. Such requirement is satis￿ed
for the lower and upper bounds in Section 5, and for some of those in Section 4. However, some of the
endpoints of the bounds obtained in Sections 4 involve randomly trimmed means, and, to the best
of my knowledge, uniform CLT for such estimators are not available, unless the fraction of trimmed
observations converges to zero as the sample size goes to in￿nity (Shorack (1997)). Alternatively,
Berry-Esseen results are available for trimmed means, provided the trimming proportion is non-
random (see, e.g., Ser￿ ing (1984)).9 Since the lower and upper bounds in Section 4 do not satisfy
either of these requirements, uniformity of the convergence of the con￿dence intervals to their
nominal level is not guaranteed, and is the subject of ongoing research.
9Chavez-Martin-Del-Campo (2005) uses these results to derive Imbens-Manski con￿dence intervals for the case of
identi￿cation and estimation of poverty measures with contaminated data.
167 Results for the Empirical Application
Tables 2-3 report respectively the bounds on the average outcome under a mandatory policy of
no illicit drug use, and the bounds on the ATE; along with the Imbens and Manski (IM) and
the Chernozhukov, Hong and Tamer (CHT) 95% con￿dence intervals, for the ￿ve di⁄erent sets of
assumptions considered in the previous sections. As predicted by the theory, the CHT con￿dence
intervals are always larger than the IM con￿dence intervals, as the former cover the entire identi￿-
cation region with a prespeci￿ed probability, while the latter cover the true parameter of interest.
In practice, in this empirical application the di⁄erence in the width of the con￿dence intervals is
relatively small. The biggest di⁄erence for the case of the average outcome under a mandatory
policy of no illicit drug use is 13% of the width of the corresponding IM con￿dence intervals, and
occurs under the MTR￿MTS assumption. The biggest di⁄erence for the case of the ATE is 3% of
the width of the corresponding IM con￿dence intervals, and occurs again under the MTR ￿MTS
assumption.
Since the outcome of interest in this application is the number of weeks an individual is unem-
ployed in a calendar year, I set K0 = 0 and K1 = 52: The ￿rst set of bounds in each Table (￿No
Assumptions￿ ) constitute the baseline of our analysis. With no assumptions on the distribution of
the missing treatments and on the treatment selection rule the bounds are necessarily wide; this is
mainly due to the non observability of latent outcomes, which for example implies that the bound
on the ATE is at least of width (K1 ￿ K0) = 52: The second set of bounds in each Table (￿Complete
Cases￿ ) assumes that the observations with missing treatments data can be ignored. To interpret
the di⁄erence in the results between the ￿rst and second row in Table 2 and in Table 3, notice that
under the maintained assumption of ignorability of the observations with missing treatments, only
the subsample of observations with complete data is used (N = 1230). On the other hand, when
nothing is assumed about the distribution of the missing treatments, all observations are used to
draw inference (N = 1345). However, as long as p ￿ P [z = 1jd = 0] is unknown, no information
can be extracted from the subsample with missing treatment data.
As 80:8% of the respondents report that they have not been under the e⁄ect of drugs during work
hours, the bounds on the average number of weeks of unemployment under a mandatory policy of
no illicit drug use are relatively narrow. Notice that the bound is much wider if nothing is assumed
about the distribution of the missing treatments, in which case the width is 13:57 weeks, than if
we assume ignorability of the observations with missing treatments data, in which case the width
is 9:98 weeks (that is, the width increases by 36% once we account for the missing treatments).
Regarding the bound on the average treatment e⁄ect (ATE), while ignoring the observations with
missing treatments data the width of the bound is equal to 52 weeks, when nothing is assumed
about the distribution of missing treatments the width enlarges to (1 + Pr(d = 0))K1 = 56:41.
17Table 2: Bounds and Con￿dence Intervals for the Average Number of Weeks of Unemployment
under a Mandatory Policy of no Illicit Drug Use: E[y(0)]
Bounds 95% IM CI 95% CHT CI
No Assumptions [1:998 ; 15:568] [1:744 ; 16:572] [0:995 ; 16:571]
Complete Cases [2:185 ; 12:162] [1:908 ; 13:116] [1:225 ; 13:121]
TMR [1:998 ; 14:715] [1:744 ; 15:592] [1:123 ; 15:590]
MTR [1:998 ; 2:736] [1:744 ; 3:029] [1:670 ; 3:063]
MTR ￿ MTS [2:472 ; 2:736] [2:161 ; 3:031] [2:112 ; 3:096]
Table 3: Bounds and Con￿dence Intervals for the ATE: E[y(1)] - E[y(0)]
Bounds 95% IM CI 95% CHT CI
No Assumptions [￿14:995 ; 41:451] [￿15:967 ; 42:295] [￿16:081 ; 42:538]
Complete Cases [￿11:535 ; 40:465] [￿12:443 ; 41:374] [￿12:611 ; 41:542]
TMR [￿11:567 ; 40:762] [￿12:478 ; 41:669] [￿12:648 ; 41:843]
MTR [ 0 ; 41:451] [ 0 ; 42:295] [ 0 ; 42:454]
MTR ￿ MTS [ 0 ; 4:962] [ 0 ; 5:982] [ 0 ; 6:173]
In order to illustrate the identifying power of assumptions on P [z = 1jd = 0], the third row
of Table 2 and the third row of Table 3 report the bounds and the 95% con￿dence intervals on
the treatment e⁄ects of interest under the maintained assumption of treatments missing at random
(TMR; note that we are not assuming d ? (y (0);y (1);z)), which can be speci￿ed as follows:
TMR : P [z = 1jd = 0] = P [z = 1jd = 1]
This assumption states that respondents who did not answer the question relative to drug abuse are
as likely as respondents who did answer the question to have been under the e⁄ect of drugs during
work hours. This assumption can be credible if for example some of the people interviewed in the
NLSY are ￿impatient￿ . Suppose that a fraction of the respondents get easily bored answering the
questionnaire, and hence don￿ t answer some of the questions, including the one on drug use. Suppose
further that drug abuse is independent from impatience; then we can assume that the treatments are
missing at random. However, unemployment outcomes may be correlated with impatience, hence
it may not be reasonable to assume that the outcomes￿distribution is identical for patient and
impatient people. Given the NLSY sample, this assumption implies that P [z = 1jd = 0] = 0:192.
Once P [z = 1jd = 0] becomes known, it is possible to use the results in Propositions 1 and 2
18to get narrower bounds on the average number of weeks of unemployment under mandatory policy
of no illicit drug use, and on the ATE. Note that under the TMR Assumption all observations
are used to draw inference (N = 1345), and information can be extracted also from the subsample
with missing treatment data, as illustrated in Section 4.
The last two rows of Tables 2￿ 3 report the bounds and the con￿dence intervals on the treatment
e⁄ects of interest, under the maintained assumption of monotone treatment response (MTR), and
under the maintained assumption of joint monotone treatment response and selection (MTR ￿
MTS). As already introduced in the previous section, such assumptions are speci￿ed as follows:
MTR : yj (1) ￿ yj (0)
MTS : E [y (t)jz = 1;d = 1] ￿ E [y (t)jz = 0;d = 1] , t 2 f0;1g
(28)
In this application, the monotone treatment response assumption states that each person￿ s un-
employment outcome is weakly increasing in conjectured use of drugs during work hours. The
monotone treatment selection assumption states that, for all t 2 f0;1g, persons who do not select
into using drugs during work hours experience a weakly lower average number of weeks of unem-
ployment than do people who do select into using drugs during work hours. In other words, the
MTS is a ￿sorting￿assumption. In this application, it states that if we divide the population in
two groups according to the received treatment, then the average outcome for the group who did
not use drugs during work hours is lower than for the group who did use it, for each t 2 T.
Manski and Pepper (2000) show that the joint MTR￿MTS Assumption is a testable hypothesis,
which should be rejected if E [yjz = u] is not weakly increasing in u. Table 1 reports that in
the NLSY sample E [yjz = 1;d = 1] = 3:267 and E [yjz = 0;d = 1] = 2:703. The 95% con￿dence
interval shows that we cannot reject the assumption that E [yjz = 1;d = 1]￿E [yjz = 0;d = 1] ￿ 0,
and that the band contains everywhere monotone non-decreasing functions. Hence I proceed on
the basis that MTR ￿ MTS assumption is consistent with the empirical evidence.
While the identifying power of the MTR Assumption can be appreciated almost exclusively for
the average number of weeks of unemployment under a mandatory policy of no illicit drug use, the
joint MTR￿MTS Assumption appears to have substantial identifying power. In particular, if we
look at E [y (1)] ￿ E [y (0)], under the maintained assumption of MTR ￿ MTS we conclude that
using drugs during work hours can increase the average number of weeks of unemployment by up
to 4:96 weeks. If we look at the 95% con￿dence intervals around the true parameter, we conclude
that this increase can be of up to 5:98 weeks. If we look at the 95% con￿dence intervals around
the bound, we conclude that this increase can be of up to 6:17 weeks.
198 Conclusions
This paper has introduced the problem of missing treatments, i.e. what we can learn from the
data about a treatment e⁄ect of interest when we do not know which treatment some individuals
have received. While for the observations for which we know the received treatment the problem is
identical to the standard one, namely the non observability of the latent outcomes, when we do not
observe the received treatments we face a new issue. Not only we have the usual latent outcome
problem, but we do not know the distribution of the treatments, and we are also unable to match
the unobserved received treatments with the observed realized outcomes.
I considered the missing treatments problem in the context of observational studies and of
survey nonresponse relative to the variable to be used as a treatment, and I showed that the
assumption of ignorability of the observations with missing treatment data can be tested. Sharp
worst case bounds were derived for the case in which no assumptions are imposed; I showed that no
information can be extracted from the observations for which the received treatment is unknown,
and that the additional degree of under-identi￿cation is proportional to the fraction of missing
data. I illustrated how to use prior information on the distribution of the missing treatments (as
for example prior knowledge of P [z = 1jd = 0] or bounds on this quantity) to shrink the width
of the bounds. Finally, I showed that under the maintained assumption of monotone treatment
response information can be extracted from the observations with missing treatment data even
without any prior knowledge of P [z = 1jd = 0].
The theoretical results were illustrated by means of an empirical application studying the e⁄ect
of drug abuse during work hours on unemployment. Given the NLSY sample, I showed that under
the maintained assumption of joint monotone treatment response and selection, using drugs during
work hours can increase the average number of weeks of unemployment by up to 4:96 weeks.
20A Proofs of Propositions
In all that follows, let Hp [P (yj￿)] denote the identi￿cation region of the distribution P (yj￿) given
the observable data and the value p ￿ P (z = 1jd = 0):
A.1 Proposition 1
Proof. Denote by ￿ the set of all probability distributions on Y ; then by Proposition 1 in Horowitz
and Manski (1995):
P [yjd = 0;z = 1] 2 Hp [P [yjd = 0;z = 1]]
Hp [P [yjd = 0;z = 1]] ￿ ￿ \
n
Q￿(1￿p) 
p ;  2 ￿
o (29)
Horowitz and Manski (1995) show that Lp and Up are respectively stochastically dominated and
stochastically dominating every other element of Hp [P [yjd = 0;z = 1]]: The result in (5) follows
because the mean is a parameter that respects stochastic dominance. When the treatments are
observable, the sharp bound on the average outcome under a mandatory policy is well known:
E [yjd = 1;z = 1]P [z = 1jd = 1] + K0P [z = 0jd = 1] ￿ P [y (1) = 1jd = 1]
￿ P [y = 1jd = 1;z = 1]P [z = 1jd = 1] + K1P [z = 0jd = 1]
Using the Law of Iterated Expectations the result in (6) follows. To get the result in (??), notice
that in absence of information on the distribution of the missing treatments, all that we can learn
on E [y (1)jd = 0] is that it ranges in [K0;K1]. Hence, the result follows.
￿
A.2 Proposition 2
Proof. To ￿nd the sharp upper and lower bounds described in Proposition 2, observe that in any
UB, E10 = K1 and E01 = K0, while in any LB, E10 = K0 and E01 = K1. Moreover, Proposition
4 in Horowitz and Manski (1995) implies that
(Lp;U1￿p) 2 Hp;(1￿p) [P [yjd = 0;z = 1];P [yjd = 0;z = 0]]:
Note that Lp is stochastically dominated by every member of Hp [P [yjd = 0;z = 1]]; while U1￿p
stochastically dominates every member of H1￿p [P [yjd = 0;z = 0]]: Hence the lower bound on
E11p￿E00 (1 ￿ p) will be given by p
R
ydLp ￿(1 ￿ p)
R
ydU1￿p: Similar considerations hold for the
upper bound. The Law of Iterated Expectations and expression (9) imply (14). To get the result










Proof. Under the monotone treatment response assumption, we have: E10 2 [K0;E00] and E01 2
[E11;K1]. The quantities that we want to bound are: E [y (1)jd = 0] = E11p + E10 (1 ￿ p) and
E [y (0) = 1jd = 0] = E00 (1 ￿ p) + E01p. Since we know that E [yjd = 0] = E11p + E00 (1 ￿ p),
and that in any upper bound E10 and E01 are at their highest possible value, and in any lower
bound they are at their lowest possible value, the result in (20) follows. Using the Law of Iterated
Expectations and given (18)-(19), we get the results in (21)-(22). To get the lower bound in (23),
subtract from the lower bound in (22) the upper bound in (21); to get the upper bound in (23),
subtract from the upper bound in (22) the lower bound in (21).
￿
B Asymptotic Distribution of the Estimated Lower and Upper
Bounds
As a ￿rst step, I introduce sample analog estimators of the population parameters appearing in
the population bounds; for ease of notation, I continue to omit covariates in all that follows. Let
^ ￿1 ￿ b E (y) = 1
N
PN




the sample analog of Pr(d = 1); and









denote the sample analog of Pr(z = 1jd = 1): Using similar notation, let E (yjd = 1) and E (yjd = 0)
be estimated by
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and E (yjz = 1;d = 1) and E (yjz = 0;d = 1) be estimated by
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ydL1￿p; and ￿U;1￿p ￿
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where ^ r(￿) is the ￿￿quantile of the empirical distribution function of yjd = 0: Under a proper
set of assumptions on the data generating process listed below, the above estimators are root￿N
consistent and asymptotically normal.10 Such assumptions are:
Assumption 1: A random sample fyi;di;zidig; i = 1;:::;N is available, such that V ar(y) < 1;
0 < Pr(d = 1) < 1; 0 < Pr(z = 1jd = 1) < 1:
Assumption 2: If an auxiliary sample of size n = N
￿ ; 0 < ￿ < 1; is available, such that
p ￿ Pr(z = 1jd = 0) can be consistently estimated using this sample, the auxiliary sample is
independent from the sample used to estimate the distribution of yjd = 0: Let ^ p denote the
estimator of p: Then ^ p satis￿es: ^ p = 0(1) if p = 0(1); and
p
n(^ p ￿ p)
d ! N (0;Vp) otherwise, so
that
p
N (^ p ￿ p)
d ! N (0;￿Vp):
Assumption 3: Q is continuously di⁄erentiable in neighborhoods of r(p) and r(1 ￿ p); and
Q0 (r(p)) > 0 and Q0 (r(1 ￿ p)) > 0:
The ￿rst assumption simply states that the researcher observes a random sample from the
population of interest. The second assumption requires that if the researcher can estimate ^ p from
an auxiliary sample, then this auxiliary sample has to be independent from that used to estimate
the distribution of yjd = 0. This assumption is necessary to obtain the asymptotic distribution of
^ ￿L and ^ ￿U; which are randomly trimmed means. The random trimming proportion is given by ^ p;
and the distribution to be trimmed is the empirical distribution function of yjd = 0: For example,
if one assumes that the treatments are missing at random, then ^ p = c Pr(z = 1jd = 1); and the
independence assumption is satis￿ed. Assumption 3 is a regularity condition needed to obtain the
asymptotic distribution of ^ ￿L and ^ ￿U (Shorack and Wellner (1986), Chapter 19).
For reasons of brevity, rather than obtaining the con￿dence sets for each of the identi￿cation
regions of Sections 4-5, I derive below the joint asymptotic distribution of all estimators listed above.
Given this asymptotic distribution, one can easily obtain the joint distribution of the estimators
of each of the lower and upper bounds in Sections 4-5 by using the delta method, and then obtain
con￿dence sets as detailed in Imbens and Manski (2004) and Chernozhukov, Hong and Tamer (2004,
Section 3.3). Alternatively, one can use the bootstrap to estimate the variance-covariance matrix
of the lower and upper bounds of interest.
10Root￿N consistency and asymptotic normality of the estimators of population means follows from standard
arguments. For a discussion of the asymptotic properties of randomly trimmed means, see Shorack and Wellner
(1986), Chapter 19. Related results are derived by Horowitz and Manski (1997).









^ ￿ ￿ ￿
^ p ￿ p
!
d ! N (0;￿);
where, denoting the elements of ￿ by ￿ij; ￿11 = V ar(y); ￿22 = Pr(d = 1)[1 ￿ Pr(d = 1)];
￿33 =
Pr(z=1jd=1)[1￿Pr(z=1jd=1)]
Pr(d=1) ; ￿44 =
V ar(yjd=1)
Pr(d=1) ; ￿55 =
V ar(yjd=0)
Pr(d=0) ; ￿66 =
V ar(yjz=1;d=1)
Pr(z=1;d=1) ; ￿77 =
V ar(yjz=0;d=1)
Pr(z=0;d=1) ; ￿12;12 = ￿Vp: Shorack and Wellner (1986, Chapter 19, Theorem 1) show that
p






K0 Udr ￿ (r(p) ￿ ￿L)
p
N (^ p ￿ p)
o
where U is the empirical process of the Uniform order statistics corresponding to the order statistics
of y1;:::;yNjd = 0: Similar results hold for ^ ￿U; ^ ￿L;1￿p; and ^ ￿U;1￿p: Given the independence of ^ p













































Regarding the covariances, those involving products of sample averages can be derived using stan-
dard results, and are available from the author upon request. Here I focus on providing the co-

































































24Given these results, one can show, for example, that the joint asymptotic distribution of the
sample analogs of the lower and upper bounds on E [y (1)jd = 0] as in equation (5), given by
#L = p
R
ydLp + (1 ￿ p)K0; #U = p
R




^ #L ￿ #L














K0 y2dQ ￿ p￿2
L + p(1 ￿ p)￿2
L ￿ 2p(1 ￿ p)￿Lr(p)
i




p(1 ￿ p)[r(1 ￿ p)]
2 +
R K1
r(1￿p) y2dQ ￿ p￿2
U + p(1 ￿ p)￿2
U ￿ 2p(1 ￿ p)￿Ur(1 ￿ p)
i







(min(s;t) ￿ st)dr(s)dr(t) ￿ (K1 ￿ r(1 ￿ p))(r(p) ￿ K0)￿Vp;
Con￿dence intervals CI#?
that asymptotically cover #? ￿ E [y (1)jd = 0] with probability at least






























Con￿dence intervals CI[#L;#U] that asymptotically cover [#L;#U] with probability (1 ￿ ￿); as


















2 ￿ I [u > 0] and (u)
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